Translating these findings to GC, combinatorial strategies targeting ALDOA/ENO1 with immunotherapy may synergize by reversing macrophage-mediated immunosuppression, as ALDOA/ENO1 expression correlates with tumor-associated macrophage infiltration. Here, ALDOA is linked to gastric cancer.